King of Prussia, PA, United States of America

Karen A Ingraham


Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Collegeville, PA (US) (2006)
  • King of Prussia, PA (US) (2007)

Company Filing History:


Years Active: 2006-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Karen A. Ingraham: Pioneering Diagnostic Solutions

Introduction: Karen A. Ingraham, based in King of Prussia, Pennsylvania, has made significant strides in the field of biotechnology through her innovative contributions. With a total of two patents to her name, Ingraham is recognized for her remarkable work with metRS2 polypeptides and polynucleotides, which have the potential to transform diagnostic methodologies.

Latest Patents: Ingraham's latest patents focus on metRS2, which involves the development of metRS2 polypeptides and the polynucleotides that encode these polypeptides. The patents detail methods for producing these polypeptides using recombinant techniques. Furthermore, they provide preferred methods for utilizing metRS2 polypeptides and polynucleotides as diagnostic reagents. These innovations enable diagnostic assays to effectively screen for microbial infections in organisms as well as infestations in various materials.

Career Highlights: Ingraham has demonstrated a strong commitment to advancing diagnostic technologies, showcasing her expertise within the industry. Her work at Replidyne, Inc. underscores her dedication to innovation and research, contributing to the development of new methodologies that enhance microbial infection diagnostics.

Collaborations: Throughout her career, Ingraham has collaborated with talented colleagues, including Daniel Robert Gentry and David John Holmes. Their collective efforts in research and development have further propelled advancement in their field, highlighting the importance of teamwork in scientific innovation.

Conclusion: Karen A. Ingraham stands out as a pioneering inventor in the realm of biotechnology. Through her cutting-edge patents and commitment to her work at Replidyne, Inc., she continues to contribute to the advancement of diagnostic practices, making significant impacts on healthcare and research. Her innovations serve as a testament to the power of ingenuity and collaboration in the pursuit of scientific excellence.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…